Avanos Medical (NYSE:AVNS) Updates FY 2024 Earnings Guidance

Avanos Medical (NYSE:AVNSGet Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.300-1.350 for the period, compared to the consensus earnings per share estimate of 1.390. The company issued revenue guidance of $683.0 million-$688.0 million, compared to the consensus revenue estimate of $695.2 million.

Avanos Medical Price Performance

AVNS stock traded up $0.03 during trading on Friday, hitting $18.71. The company had a trading volume of 441,974 shares, compared to its average volume of 237,900. The company has a fifty day moving average price of $23.23 and a two-hundred day moving average price of $21.48. The company has a current ratio of 2.22, a quick ratio of 1.49 and a debt-to-equity ratio of 0.12. Avanos Medical has a fifty-two week low of $17.39 and a fifty-two week high of $25.36. The company has a market cap of $859.72 million, a P/E ratio of 54.94 and a beta of 0.91.

Avanos Medical (NYSE:AVNSGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.36. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The firm had revenue of $170.40 million during the quarter, compared to the consensus estimate of $175.03 million. Equities research analysts expect that Avanos Medical will post 1.33 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, StockNews.com upgraded Avanos Medical from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 26th.

View Our Latest Report on AVNS

Avanos Medical Company Profile

(Get Free Report)

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Further Reading

Earnings History and Estimates for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.